• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
ALEXMED ePosters
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 7 (2025)
Volume Volume 6 (2024)
Volume Volume 5 (2023)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 4 (2022)
Volume Volume 3 (2021)
Volume Volume 2 (2020)
Volume Volume 1 (2019)
Nafea, D., Nazeer, A., El-Nenaey, W., Hassan, N. (2023). THE ASSESSMENT OF SERUM CITRULLINE AS A SEPSIS MARKER IN EARLY DETECTION OF SEPSIS IN ACUTE LEUKEMIA PATIENTS. ALEXMED ePosters, 5(4), 20-21. doi: 10.21608/alexpo.2023.244809.1717
Dalia Ahmad Nafea; Aida Aly Nazeer; Wafaa Ahmed El-Nenaey; Nermeen Yousri Ali Hassan. "THE ASSESSMENT OF SERUM CITRULLINE AS A SEPSIS MARKER IN EARLY DETECTION OF SEPSIS IN ACUTE LEUKEMIA PATIENTS". ALEXMED ePosters, 5, 4, 2023, 20-21. doi: 10.21608/alexpo.2023.244809.1717
Nafea, D., Nazeer, A., El-Nenaey, W., Hassan, N. (2023). 'THE ASSESSMENT OF SERUM CITRULLINE AS A SEPSIS MARKER IN EARLY DETECTION OF SEPSIS IN ACUTE LEUKEMIA PATIENTS', ALEXMED ePosters, 5(4), pp. 20-21. doi: 10.21608/alexpo.2023.244809.1717
Nafea, D., Nazeer, A., El-Nenaey, W., Hassan, N. THE ASSESSMENT OF SERUM CITRULLINE AS A SEPSIS MARKER IN EARLY DETECTION OF SEPSIS IN ACUTE LEUKEMIA PATIENTS. ALEXMED ePosters, 2023; 5(4): 20-21. doi: 10.21608/alexpo.2023.244809.1717

THE ASSESSMENT OF SERUM CITRULLINE AS A SEPSIS MARKER IN EARLY DETECTION OF SEPSIS IN ACUTE LEUKEMIA PATIENTS

Article 1, Volume 5, Issue 4, December 2023, Page 20-21  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2023.244809.1717
View on SCiNiTO View on SCiNiTO
Authors
Dalia Ahmad Nafea1; Aida Aly Nazeer2; Wafaa Ahmed El-Nenaey3; Nermeen Yousri Ali Hassan email 2
1Department of Internal Medicine – Hematology Unit, Faculty of Medicine, Alexandria University
2Department of Internal Medicine, Faculty of Medicine, Alexandria University
3Department of Clinical and Chemical Pathology, Faculty of Medicine, Alexandria University
Abstract
A serious organ failure known as sepsis is brought on by a poorly controlled host response to an infection. This study assessed Citrulline role as a marker to sepsis in patients with acute leukemia after induction chemotherapy. The study found that ANC was significantly lower in acute leukemia patientsafter induction chemotherapy compared to controls, and both CRP and PCT levels were significantly higher in acute leukemia patients on the first day of fever compared to the seventh day of fever. Citrulline levels were significantly lower in acute leukemia patients on the first day of fever compared to the seventh day of fever and in controls. Citrulline demonstrated promise as a marker for detecting early bacteremia in patients with acute leukemia.. There were negative correlations between citrulline and APACHE II, and positive correlations between CRP and APACHE II.
AIM OF THE WORK:
This study purpose was to assess citrulline's potential as an early sepsis marker in acute leukemia patients receiving chemotherapy
Keywords
SERUM CITRULLINE; SEPSIS; ACUTE LEUKEMIA
Supplementary Files
download 1717 19 (8) (1).pdf
Statistics
Article View: 101
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.